Donepezil HCl and Memantine HCl Tablets are a combination medicine used to manage moderate to severe Alzheimer’s disease. They work together to help improve cognitive function and daily living abilities in affected patients.

Here are the key details:

• Composition: Each tablet contains:

  • Donepezil hydrochloride – a cholinesterase inhibitor.

  • Memantine hydrochloride – an NMDA receptor antagonist.

  • Available in various fixed-dose combinations, such as Donepezil 10 mg + Memantine 10 mg.

• Dosage Form: Oral tablets, usually taken once or twice daily, as prescribed by a doctor.

• Mode of Action:

  • Donepezil: Inhibits acetylcholinesterase, increasing acetylcholine in the brain to improve nerve cell communication.

  • Memantine: Regulates the activity of glutamate, preventing overstimulation of nerve cells that can cause cell damage.

  • Together, they target different pathways involved in Alzheimer’s, providing a broader approach to symptom management.

• Uses:

  • Management of moderate to severe Alzheimer’s disease.

  • Helps improve memory, attention, reasoning, and daily functioning.

  • May slow symptom progression and enhance quality of life.

• Treatment Goal: To reduce cognitive decline, manage behavioral symptoms, and support daily activities in patients with Alzheimer’s disease.

• Side Effects:

  • Common: nausea, vomiting, diarrhea, dizziness, headache, fatigue, sleep disturbances.

  • Less common/serious: slow heart rate (bradycardia), low blood pressure, hallucinations, confusion, gastrointestinal bleeding.

• Precautions:

  • Use cautiously in patients with heart problems, severe kidney or liver disease, or a history of seizures.

  • Not a cure for Alzheimer’s; intended to manage symptoms and improve quality of life.

  • Regular monitoring by a healthcare provider is recommended.

  • Interactions may occur with anticholinergic drugs, NMDA antagonists, or other medicines affecting heart rhythm.

👉 This combination is often prescribed when Donepezil alone is insufficient, as Memantine adds an additional mechanism to help slow disease progression.